AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16048137
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 800 IU (20 microg) daily for 12 months (Study 2)
Trial: 11993510
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (sulfasalazine and azathioprine)
Trial: 11993510
Drug: Sulfasalazine monotherapy
RxNorm normalized name: Sulfasalazine
DrugBank: Sulfasalazine (DB00795)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulfasalazine monotherapy (placebo)
Trial: 8534781
Drug: Theophylline (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (loading dose 5 mg/kg i.v., maintenance dose 2.5 mg/kg/12 h)
Trial: 8534781
Drug: Caffeine (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (loading dose 10 mg/kg i.v., maintenance dose 2.5 mg/kg/12 h)
Trial: 25973526
Drug: MNTX (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MNTX (8 mg or 12 mg by body weight, administered every other day for two weeks)
Trial: 25973526
Drug: Placebo (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (administered every other day for two weeks)
Trial: 24172161
Drug: Escitalopram (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (10 and 20 mg/day)
Trial: 22859237
Drug: Alefacept 15
RxNorm normalized name: alefacept 15 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alefacept 15 mg intramuscularly once weekly for 12 weeks plus nbUVB three times weekly
Trial: 22859237
Drug: Alefacept 15
RxNorm normalized name: alefacept 15 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alefacept 15 mg intramuscularly once weekly for 12 weeks
Trial: 17594251
Drug: Preparation stage
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation stage at baseline
Trial: 15226169
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medications
Trial: 9822095
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (alpha-tocopherol acetate, 300 mg/day)
Trial: 31525613
Drug: Psychoeducational intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychoeducational intervention program (PIP) consisting of 12 weekly group sessions.
Trial: 27500675
Drug: High-frequency intrapulmonary
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-frequency intrapulmonary ventilation along with mineral water baths, inhalations, exercise therapy, manual massage, intake of extract maral root, and 'Yantar antiox' preparation.
Trial: 27500675
Drug: Standard rehabilitative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard rehabilitative treatment without high-frequency intrapulmonary ventilation.
Trial: 15817723
Drug: Glycerol ingestion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerol ingestion (GI) - 37 ml water/l total body water plus 1.5 g glycerol/l total body water
Trial: 15817723
Drug: Water ingestion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water ingestion (WI) - 37 ml water/l total body water
Trial: 30149898
Drug: CA125 (>35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CA125 (>35 U/mL) in postmenopausal women
Trial: 30149898
Drug: HE4 (>140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HE4 (>140 pmol/L) in postmenopausal women
Trial: 30149898
Drug: HE4 (>70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HE4 (>70 pmol/L) in premenopausal women
Trial: 26123137
Drug: UFT 400
RxNorm normalized name: UFT
DrugBank: Tegafur-uracil (DB09327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT 400 mg/d (n=61)
Trial: 24971988
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment with GnRH agonists
Trial: 22695211
Drug: Nicorette(®) Microtab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorette(®) Microtab (tablet)
Trial: 20157322
Drug: Family-based behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-based behavioral treatment (intervention)
Trial: 18310554
Drug: Proxy consent
RxNorm normalized name: proxyphylline
DrugBank: Proxyphylline (DB13449)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proxy consent for clinical trial enrollment (simvastatin treatment)
Trial: 12808261
Drug: Cholesterol levels
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol levels below 240 mg/dl (6.20 mmol/L)
Trial: 12808261
Drug: Cholesterol levels
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol levels below 220 mg/dl (5.68 mmol/L)
Trial: 28817437
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy followed by gastrectomy with D1+ lymphadenectomy
Trial: 22077962
Drug: 1% WBI-1001
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% WBI-1001 cream applied twice daily for 12 weeks
Trial: 22077962
Drug: 1% WBI-1001
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% WBI-1001 cream
Trial: 11863301
Drug: Aspirin treatment
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin treatment (400 mg, one dose daily for 3 days, starting 12 hours before the flight)
Trial: 11863301
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH) (one dose of enoxaparin injected between 2 and 4 hours before the flight, weight-adjusted 1,000 IU per 10 kg of body weight)
Trial: 7877544
Drug: Pravastatin (20‐40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (20‐40 mg/day)
Trial: 2227075
Drug: Intravenous doxofylline
RxNorm normalized name: doxofylline
DrugBank: Doxofylline (DB09273)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous doxofylline (100 mg as a single dose over 10 min)
Trial: 2227075
Drug: Oral doxofylline
RxNorm normalized name: doxofylline
DrugBank: Doxofylline (DB09273)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral doxofylline (400 mg given twice daily for 5 days)
Trial: 1036709
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg raubasin
Trial: 1036709
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg bencyclan
Trial: 1036709
Drug: salt solution
RxNorm normalized name: Salt solutions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: salt solution (placebo)
Trial: 30171497
Drug: Tipifarnib 300
RxNorm normalized name: Tipifarnib
DrugBank: Tipifarnib (DB04960)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tipifarnib 300 mg twice daily plus Erlotinib 150 mg once daily
Trial: 29565149
Drug: Whole milk
RxNorm normalized name: Calcium fortified whole milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole milk (300 Kcals; G1) daily for 23 weeks
Trial: 29565149
Drug: Fortified milk
RxNorm normalized name: Fortified milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fortified milk (300 Kcals; G2) daily for 23 weeks
Trial: 19877976
Drug: Pill Placebo
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pill Placebo (PBO)
Trial: 10229289
Drug: Switch to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switch to insulin therapy
Trial: 8947995
Drug: Oral lithium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral lithium carbonate (mean daily dose 437 +/- 185 mg, range 150-900 mg)
Trial: 28817727
Drug: Oral lithium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral lithium carbonate
Trial: 2006773
Drug: Oral slow-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral slow-release theophylline (4.7 to 16.6 mg/kg/day, divided into two doses)
Trial: 8688399
Drug: Ritodrine sustained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritodrine sustained release capsules (40 mg, 3 times a day for 7 days)
Trial: 8688399
Drug: Placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules (identical to ritodrine)
Trial: 1839656
Drug: Isradipine 2.5
RxNorm normalized name: isradipine 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine 2.5 mg or 5.0 mg/day
Trial: 31607019
Drug: Ultrasound-guided erector
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided erector spinae block combined with oral drug pregabalin
Trial: 31607019
Drug: Oral drug
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral drug pregabalin
Trial: 29394969
Drug: Lactulose plus
RxNorm normalized name: Lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lactulose plus rifaximin 550 mg twice daily for 10 days
Trial: 29394969
Drug: Lactulose alone
RxNorm normalized name: Lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lactulose alone 30 ml thrice daily for 10 days
Trial: 22170364
Drug: DASH diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DASH diet (28 g beef/d)
Trial: 22170364
Drug: BOLD diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BOLD diet (113 g beef/d)
Trial: 22170364
Drug: BOLD+ diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BOLD+ diet (153 g beef/d)
Trial: 12792353
Drug: Protease inhibitor
RxNorm normalized name: Protease inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease inhibitor (PI) treatment
Trial: 12792353
Drug: Non-protease inhibitor
RxNorm normalized name: Protease inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-protease inhibitor (non-PI) treatment
Trial: 10577698
Drug: Standard radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard radiotherapy with carboplatin 70 mg/m2/day for 5 days during weeks 1 and 5 (R6C)
Trial: 10577698
Drug: Accelerated radiotherapy
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated radiotherapy with carboplatin 70 mg/m2/day for 5 days during week 1 (R3C)
Trial: 8950879
Drug: Alendronate (initially
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (initially 5 mg daily, increased to 10 mg daily at 24 months)
Trial: 6783861
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of beta-blockers and diuretic agents (Cardiotensin)
Trial: 6783861
Drug: Sustained-release form
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release form of beta-blockers and diuretic agents
Trial: 6783861
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of beta-blockers and diuretic agents
Trial: 31490300
Drug: Intralesional triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intralesional triamcinolone 10 mg/mL
Trial: 31490300
Drug: Intralesional triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intralesional triamcinolone 40 mg/mL
Trial: 30886139
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with hemoglobin (Hb) ≥ 12 g/dl
Trial: 30886139
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with hemoglobin (Hb) ≥ 12 g/dl including depth of response (and MRD)
Trial: 22708608
Drug: Transdermal alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal alcohol concentration (TAC)
Trial: 19477972
Drug: Occlusal adjustment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occlusal adjustment (treatment group)
Trial: 17264719
Drug: Sevoflurane inhalation
RxNorm normalized name: Sevoflurane Inhalation Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevoflurane inhalation at 0.5-1 vol% end-tidal concentrations
Trial: 11927756
Drug: Psychological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological treatment conditions (collapsed for this study)
Trial: 9830233
Drug: Alendronate sodium
RxNorm normalized name: Alendronate Sodium
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate sodium 10 mg
Trial: 2476624
Drug: Felodipine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine (1 mg, intravenously)
Trial: 26114854
Drug: 12 week
RxNorm normalized name: risedronate sodium 35 MG Oral Tablet, 12 Week Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 week multi-disciplinary lifestyle intervention (physical activity, nutrition education, cognitive behavioural therapy)
Trial: 22146117
Drug: NLP therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NLP therapy
Trial: 19203221
Drug: Bone marrow-derived
RxNorm normalized name: Allogeneic human bone marrow-derived mpc
DrugBank: Rexlemestrocel-L (DB17606)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone marrow-derived cells (BMC) therapy
Trial: 16702369
Drug: Combination testing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination testing (carcinogenic HPV testing or cytology)
Trial: 16702369
Drug: Combination testing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination testing
Trial: 15274670
Drug: KC 11458
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: KC 11458 (8 mg t.d.s. for 8 days)
Trial: 8214733
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no previous drug injected)
Trial: 3446416
Drug: Salbutamol ointment
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol ointment (1% salbutamol base in white soft paraffin) b.d. for 2 weeks
Trial: 30857385
Drug: Dexmedetomidine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine infusion during sevoflurane anesthesia
Trial: 30857385
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion during sevoflurane anesthesia
Trial: 25513965
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of ticagrelor (90 mg/bid) and warfarin
Trial: 25513965
Drug: Triple antithrombosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple antithrombosis therapy (clopidogrel + aspirin + warfarin)
Trial: 16537707
Drug: Nonsteroidal anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal anti-inflammatory drug (NSAID) use
Trial: 16537707
Drug: Nonsteroidal anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal anti-inflammatory drug (NSAID) non-use
Trial: 8239849
Drug: Nabumetone, 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabumetone, 1000 mg
Trial: 8239849
Drug: Ibuprofen, 600
RxNorm normalized name: Ibuprofen, 600 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen, 600 mg four times daily
Trial: 8239849
Drug: Ibuprofen plus
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen plus Misoprostol, 600 mg and 200 micrograms four times daily
Trial: 3898700
Drug: Diazepam (0.185
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.185 mg/kg)
Trial: 3898700
Drug: Diazepam (0.185
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.185 mg/kg) plus droperidol (0.09 mg/kg)
Trial: 3898700
Drug: Diazepam (0.135
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.135 mg/kg) plus droperidol (0.09 mg/kg)
Trial: 22006202
Drug: tofacitinib 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tofacitinib 3 mg twice daily
Trial: 22006202
Drug: tofacitinib 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tofacitinib 20 mg/day
Trial: 18049022
Drug: 75 mg/day
RxNorm normalized name: Lyllana 0.075 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg/day dipyridamole
Trial: 18049022
Drug: 300 mg/day
RxNorm normalized name: alpelisib 300 mg/day (150 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/day dipyridamole
Trial: 1618361
Drug: no antihypertensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no antihypertensive therapy (control)
Trial: 30686326
Drug: Robot-assisted reach
RxNorm normalized name: beach strawberry extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robot-assisted reach training with guidance force (RT-G)
Trial: 29272062
Drug: Intensive Insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive Insulin Treatment (IIT) - glargine/glulisine
Trial: 29272062
Drug: Initial Combined
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial Combined Oral Antidiabetic Drug (COAD) therapy - glimepiride/metformin
Trial: 24450500
Drug: High whey
RxNorm normalized name: whey protein hydrolysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High whey protein, leucine-enriched supplement (20 g whey protein, 3g total leucine, 150 kcal)
Trial: 22500661
Drug: Collagen hydrolysate
RxNorm normalized name: collagen, hydrolyzed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen hydrolysate 1200 mg/day
Trial: 17573520
Drug: Prophylactic tadalafil
RxNorm normalized name: Tadalafil
DrugBank: Tadalafil (DB00820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prophylactic tadalafil (10 mg)
Trial: 17573520
Drug: Prophylactic dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prophylactic dexamethasone (8 mg)
Trial: 15964386
Drug: sirolimus, tacrolimus,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sirolimus, tacrolimus, low-dose rabbit antithymocyte globulin, and glucocorticoids
Trial: 8537277
Drug: Lomefloxacin 400
RxNorm normalized name: lomefloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lomefloxacin 400 mg once daily for 5 days
Trial: 18324566
Drug: All subjects
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All subjects (regardless of treatment condition)
Trial: 15944869
Drug: Sibutramine 15
RxNorm normalized name: sibutramine 15 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 15 mg o. d. for 3 months
Trial: 12886917
Drug: ondansetron (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron (0.1 mg x kg‐1)
Trial: 12886917
Drug: cyclizine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cyclizine (20 mg)
Trial: 10391662
Drug: HDL-raising therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HDL-raising therapy
Trial: 1997698
Drug: Oral bacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bacillus Calmette-Guerin (BCG)
Trial: 6206321
Drug: Oral tocainide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tocainide
Trial: 27030325
Drug: Nebulized budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Nebulized budesonide 4 mg/day
Trial: 22534712
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy methods applied during a monthly rehabilitation tour
Trial: 22534712
Drug: Physical methods
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical methods of treatment
Trial: 20367417
Drug: Low-dose teriparatide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose teriparatide (20 microg per day)
Trial: 20367417
Drug: High-dose teriparatide
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: High-dose teriparatide (40 microg per day)
Trial: 8551532
Drug: Continuous vocalization
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous vocalization for 30 minutes after botulinum toxin injections
Trial: 8551532
Drug: Vocal rest
RxNorm normalized name: Rest Simply
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vocal rest for 30 minutes after botulinum toxin injections
Trial: 3023276
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 mg three times daily)